Cardiva Announces Presentation at the 2008 UBS Global Life Sciences Conference
About Cardiva Medical, Inc.
Cardiva Medical, Inc. is a privately held medical device company thatdesigns, develops and commercializes endovascular products which help the bodyheal itself. In 2005, Cardiva launched its first product into the vesselclosure market, the Boomerang Wire(TM) System, which demonstrated unsurpassedease-of-use and safety. In January 2008, Cardiva launched its latest vesselclosure system, the Cardiva Catalyst II, which incorporates haemostatic agentsto accelerate the body's own coagulation pathway quickly facilitating vesselclosure and healing of the vascular access site. Cardiva was presented theprestigious Frost & Sullivan Award in 2007, which recognizes entrepreneurialexcellence in the U.S. angioplasty and vascular closure devices market. Foradditional information about Cardiva please see our website athttp://www.cardivamedical.com.
Certain statements in this press release are forward-looking within themeaning of the Private Securities Litigation Reform Act of 1995. Thesestatements may be identified by the use of forward-looking words such as"anticipate," "believe," "forecast," "estimated" and "intend," among others.These forward-looking statements are based on Cardiva's current expectationsand actual results could differ materially. Cardiva does not undertake anobligation to update or revise any forward-looking statement. Cardiva,Boomerang and Catalyst System are trademarks/registered trademarks of CardivaMedical, Inc.Details of the presentation follow: Date: Wednesday September 24, 2008 Time: 3:00 p.m. (EST) Location: The Grand Hyatt Grand Central Speaker: Augustine Lien, Chairman and CEO
SOURCE Cardiva Medical, Inc.
You May Also Like